Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign Everything Else, Added, 2016 Q4

CITADEL ADVISORS LLC historic quarter change: Foreign Everything Else, Added

In partnership units, exchange-traded notes and anything else (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 584 positions, added to 450, reduced 474 and sold out of 613.

  • Q4 2016: Stock GW PHARMACEUTICALS PLC; Country of operation —; Class Depository Receipt; Shares before 2,864.
  • Q4 2016: Stock MOMO INC; Country of operation —; Class Depository Receipt; Shares before 190,047.
  • Q4 2016: Stock AC IMMUNE SA; Country of operation Switzerland; Class Cmn; Shares before 74,858.
  • Q4 2016: Stock ROYAL DUTCH SHELL PLC; Country of operation —; Class Depository Receipt; Shares before 40,572.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2016GW PHARMACEUTICALS PLC
CUSIP 36197T103
—Depository Receipt2,86481,574+78,710$380$9,116+$8,7362017-02-10
Q4 2016MOMO INC
CUSIP 60879B107
—Depository Receipt190,047536,055+346,008$4,276$9,853+$5,5772017-02-10
Q4 2016AC IMMUNE SA
CUSIP H00263105
SwitzerlandCmn74,858373,473+298,615$1,233$4,848+$3,6152017-02-10
Q4 2016ROYAL DUTCH SHELL PLC
CUSIP 780259107
—Depository Receipt40,57289,261+48,689$2,143$5,174+$3,0312017-02-10
Q4 2016TOTAL S A
CUSIP 89151E109
—Depository Receipt4,89732,879+27,982$234$1,676+$1,4422017-02-10
Q4 2016AMARIN CORP PLC
CUSIP 023111206
—Depository Receipt23,640146,472+122,832$75$451+$3762017-02-10
Q4 2016BROOKFIELD INFRAST PARTNERS
CUSIP G16252101
BermudaCmn8,23419,348+11,114$285$648+$3632017-02-10
Q4 2016EURONAV NV ANTWERPEN
CUSIP B38564108
BelgiumCmn25,15745,317+20,160$192$360+$1682017-02-10
Q4 2016BRF SA
CUSIP 10552T107
—Depository Receipt36,01546,580+10,565$614$688+$742017-02-10
Q4 2016BANCOLOMBIA S A
CUSIP 05968L102
—Depository Receipt6,5777,753+1,176$257$284+$272017-02-10
Q4 2016TATA MTRS LTD
CUSIP 876568502
—Depository Receipt26,30630,308+4,002$1,052$1,042-$102017-02-10
Q4 2016ANGLOGOLD ASHANTI LTD
CUSIP 035128206
—Depository Receipt16,10023,591+7,491$256$248-$82017-02-10